Sobre este pódcast
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
416 episodios · business
The Readout Loud
Último episodioWhy two promising heart drugs flopped and what's next
Sobre este pódcast
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodios recientes
- 411: Capricor's data clash and a fugitive in the C-suite30 jul · 37 min
- 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing23 jul · 1 h 04 min
- 409: Predicting biotech clinical trials & a new Alzheimer's drug controversy16 jul · 36 min
- 408: Whistleblower takes on health insurance and FDA commissioner candidates9 jul · 44 min
- 407: The mysterious case of Eli Lilly's obesity drug25 jun · 43 min
- 406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises18 jun · 36 min
- 405: An obesity drug deep-dive, and peptides move mainstream11 jun · 36 min
- 404: What RevMed's pancreatic cancer drug meant for one patient4 jun · 38 min
- 403: Biotech exec Jeremy Levin on the industry's strategic turning point28 may · 47 min
- 402: Guarding biotech from China and big bets in longevity21 may · 44 min
podlinkr.com/es/the-readout-loud
Para un cartel o una diapositiva.